Mason Street Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-109,525
| Closed | -$18.5M | – | 686 |
|
|
2020
Q4 | $18.5M | Sell |
109,525
-1,976
| -2% | -$295K | 0.31% | 53 |
|
|
2020
Q3 | $16.5M | Sell |
111,501
-8,734
| -7% | -$1.35M | 0.32% | 55 |
|
|
2020
Q2 | $19.7M | Sell |
120,235
-315
| -0.3% | -$48.4K | 0.4% | 43 |
|
|
2020
Q1 | $16.7M | Hold |
120,550
| – | – | 0.38% | 47 |
|
|
2019
Q4 | $15.8M | Sell |
120,550
-488
| -0.4% | -$56.6K | 0.3% | 61 |
|
|
2019
Q3 | $13.5M | Sell |
121,038
-2,189
| -2% | -$244K | 0.28% | 64 |
|
|
2019
Q2 | $13.7M | Buy |
123,227
+27
| +0% | +$3.18K | 0.29% | 62 |
|
|
2019
Q1 | $16M | Sell |
123,200
-9,721
| -7% | -$1.18M | 0.32% | 58 |
|
|
2018
Q4 | $15.4M | Sell |
132,921
-1,451
| -1% | -$162K | 0.37% | 47 |
|
|
2018
Q3 | $14.4M | Buy |
134,372
+358
| +0.3% | +$35.8K | 0.3% | 62 |
|
|
2018
Q2 | $11.4M | Sell |
134,014
-286
| -0.2% | -$23.5K | 0.25% | 68 |
|
|
2018
Q1 | $10.4M | Sell |
134,300
-656
| -0.5% | -$52.8K | 0.24% | 75 |
|
|
2017
Q4 | $11.4M | Buy |
134,956
+459
| +0.3% | +$39.1K | 0.26% | 72 |
|
|
2017
Q3 | $11.5M | Sell |
134,497
-265
| -0.2% | -$21.7K | 0.27% | 65 |
|
|
2017
Q2 | $11.1M | Buy |
134,762
+584
| +0.4% | +$47.6K | 0.28% | 63 |
|
|
2017
Q1 | $11.3M | Buy |
134,178
+1,285
| +1% | +$103K | 0.29% | 60 |
|
|
2016
Q4 | $9.77M | Buy |
132,893
+1,485
| +1% | +$111K | 0.26% | 67 |
|
|
2016
Q3 | $10.5M | Buy |
131,408
+569
| +0.4% | +$45.5K | 0.3% | 58 |
|
|
2016
Q2 | $10.3M | Buy |
130,839
+1,186
| +0.9% | +$89.3K | 0.3% | 59 |
|
|
2016
Q1 | $9.34M | Buy |
129,653
+2,151
| +2% | +$163K | 0.28% | 64 |
|
|
2015
Q4 | $10.7M | Buy |
127,502
+1,284
| +1% | +$107K | 0.34% | 58 |
|
|
2015
Q3 | $10.6M | Buy |
126,218
+470
| +0.4% | +$39.7K | 0.36% | 56 |
|
|
2015
Q2 | $10.5M | Sell |
125,748
-174
| -0.1% | -$13.3K | 0.32% | 61 |
|
|
2015
Q1 | $9.15M | Sell |
125,922
-33,556
| -21% | -$2.39M | 0.28% | 69 |
|
|
2014
Q4 | $11M | Sell |
159,478
-1,473
| -0.9% | -$99.4K | 0.08% | 313 |
|
|
2014
Q3 | $10.4M | Sell |
160,951
-771
| -0.5% | -$48.8K | 0.08% | 294 |
|
|
2014
Q2 | $10.1M | Sell |
161,722
-1,662
| -1% | -$99.2K | 0.08% | 311 |
|
|
2014
Q1 | $9.62M | Sell |
163,384
-1,200
| -0.7% | -$67K | 0.08% | 314 |
|
|
2013
Q4 | $8.39M | Sell |
164,584
-141,865
| -46% | -$7.1M | 0.07% | 341 |
|
|
2013
Q3 | $15.4M | Buy |
306,449
+6,898
| +2% | +$361K | 0.18% | 160 |
|
|
2013
Q2 | $14.7M | Buy |
+299,551
| New | +$16.3M | 0.16% | 175 |
|
Other funds holding LLY
Mason Street Advisors's LLY Position: Q1 2021 in Review
Mason Street Advisors sold out of Eli Lilly (LLY) in Q1 2021, closing a stake of 109,525 shares — an estimated $18.5M sold.
Mason Street Advisors first reported a position in LLY in Q2 2013 and held it in 31 quarters. The position peaked at $19.7M in Q2 2020. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.
- Mason Street Advisors reported no remaining Eli Lilly position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 109,525 Eli Lilly shares in Q1 2021, an estimated $18.5M.
- Mason Street Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Eli Lilly position peaked at $19.7M in Q2 2020.
- 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.